• Coagulation Factor VIII Activity Assay, Plasma
  • Colon Cancer Multi-Gene Panel, NGS (ColoNext®, COLONSEQ, COLONSEQPlus)
  • Bilirubin Total, Serum
  • Platelet Function Analysis
  • Multi Gene Methylation Assay for Hepatocellular Carcinoma by NGS (HelioLiver™, HelioHCC™ Trace, EarlyDx MethylScan™)
  • Group A Streptococcus (Streptococcus pyogenes) Antibody (Streptozyme), Titer
  • Partial Thromboplastin Time (PTT)
  • Megaloblastic anemia (Myelodysplastic syndrome)
  • Dihydropyrimidine Dehydrogenase (DPYD) Genotyping
  • MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Serum
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Serum
Medical Test

Reference Ranges
Access to Cancer Antigen (CA) 19-9, Serum is restricted.
Loading...